These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3485230)

  • 41. The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) to Parkinson's disease.
    Bannon MJ; Goedert M; Williams B
    Biochem Pharmacol; 1984 Sep; 33(17):2697-8. PubMed ID: 6331828
    [No Abstract]   [Full Text] [Related]  

  • 42. High-affinity binding sites for [3H]MPTP may correspond to monamine oxidase.
    Parsons B; Rainbow TC
    Eur J Pharmacol; 1984 Jul; 102(2):375-7. PubMed ID: 6332739
    [No Abstract]   [Full Text] [Related]  

  • 43. [Biochemistry of the physiopathologic and clinical aspects of free radicals in cerebral degenerative diseases such as Alzheimer's and Parkinson diseases].
    Hirai S
    Nihon Rinsho; 1988 Oct; 46(10):2184-9. PubMed ID: 3266509
    [No Abstract]   [Full Text] [Related]  

  • 44. Does an endogenous methylpyridinium analogue cause Parkinson's disease?
    Testa B; Naylor R; Costall B; Jenner P; Marsden CD
    J Pharm Pharmacol; 1985 Sep; 37(9):679-80. PubMed ID: 2867199
    [No Abstract]   [Full Text] [Related]  

  • 45. Aetiology of Parkinson's disease.
    Lancet; 1984 Jan; 1(8369):167. PubMed ID: 6140477
    [No Abstract]   [Full Text] [Related]  

  • 46. Homocysteine, folate deficiency, and Parkinson's disease.
    Miller JW
    Nutr Rev; 2002 Dec; 60(12):410-3. PubMed ID: 12521146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [11C]MPTP: a potential tracer for Parkinson's disease research in laboratory animals.
    Livni E; Spellman JP; Correia JA; Alpert NM; Brownell GL; Strauss HW; Elmaleh DR
    J Nucl Med; 1986 Oct; 27(10):1600-3. PubMed ID: 3489823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurochemical pathology and the etiology of Parkinson's disease: basic facts and hypothetical possibilities.
    Hornykiewicz O
    Mt Sinai J Med; 1988 Jan; 55(1):11-20. PubMed ID: 3279301
    [No Abstract]   [Full Text] [Related]  

  • 49. Metabolic aspects of aging brain and related disorders.
    Battistin L; Rigo A; Bracco F; Dam M; Pizzolato G
    Gerontology; 1987; 33(3-4):253-8. PubMed ID: 3498665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commentary on "Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)'.
    Di Monte D; Wu EY; Smith MT
    Toxicol Lett; 1989 Aug; 48(2):117-9. PubMed ID: 2788940
    [No Abstract]   [Full Text] [Related]  

  • 51. MPTP-like molecules and Parkinson's disease.
    Fellman JH; Nutt JN
    Lancet; 1985 Apr; 1(8434):924. PubMed ID: 2858762
    [No Abstract]   [Full Text] [Related]  

  • 52. Quantitative autoradiography of [3H]MPTP binding sites in rat brain.
    Wieczorek CM; Parsons B; Rainbow TC
    Eur J Pharmacol; 1984 Mar; 98(3-4):453-4. PubMed ID: 6609829
    [No Abstract]   [Full Text] [Related]  

  • 53. Age factors loom in parkinsonian research.
    Lewin R
    Science; 1986 Dec; 234(4781):1200-1. PubMed ID: 3490694
    [No Abstract]   [Full Text] [Related]  

  • 54. Mechanisms underlying neuronal degeneration in Parkinson's disease: an experimental and theoretical treatise.
    Langston JW
    Mov Disord; 1989; 4 Suppl 1():S15-25. PubMed ID: 2542782
    [No Abstract]   [Full Text] [Related]  

  • 55. Parkinson's disease, vitamin E, and mitochondrial energy metabolism.
    Hornsby PJ
    Arch Neurol; 1989 Aug; 46(8):840-1. PubMed ID: 2787979
    [No Abstract]   [Full Text] [Related]  

  • 56. The etiology of Parkinson's disease with emphasis on the MPTP story.
    Langston JW
    Neurology; 1996 Dec; 47(6 Suppl 3):S153-60. PubMed ID: 8959984
    [No Abstract]   [Full Text] [Related]  

  • 57. [Changes in brain level of neurotransmitters].
    Kanazawa I
    Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1148-52. PubMed ID: 1680945
    [No Abstract]   [Full Text] [Related]  

  • 58. The potential use of vitamin E and selenium in parkinsonism.
    Cadet JL
    Med Hypotheses; 1986 May; 20(1):87-94. PubMed ID: 3088403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease.
    Leonardi ET; Mytilineou C
    Adv Exp Med Biol; 1998; 446():203-22. PubMed ID: 10079845
    [No Abstract]   [Full Text] [Related]  

  • 60. Parkinson's disease. Clues to aetiology from a toxin.
    Snyder SH
    Nature; 1984 Oct 11-17; 311(5986):514. PubMed ID: 6332990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.